Drugs & Pharmaceuticals

We are approaching the two-year anniversary of the Emergency Use Authorization (EUA) of Paxlovid, the most effective COVID-19 antiviral drug.

Oxycodone, heroin, fentanyl, xylazine. And now we have nitazines, for example, isotonitazine, which is about ten times more potent than fentanyl and increasingly showing up in street drugs.

Today, an FDA panel voted unanimously that phenylephrine (PE), the drug that replaced pseudoephedrine (Sudafed) as an over-the-counter decongestant, is ineffective, something I

I just got the following email from KinderFarms, a "natural" kid's medicine company that objects to all the "unnatural" things found in children's OTC medications. Damn, they picked the wrong person to spam with this.

Just what we don't need. As if the unparalleled destruction being wrought by illicit fentanyl isn't bad enough.  

I wrote about the efficacy, mostly the lack thereof, of Tylenol (aka, acetaminophen, paracetamol) back in 2017 using reviews from the highly-regarde

JB: A new report in USA Today is certainly looking for readers. The title clearly reflects this: “Not 'if' but 'when': Antibiotic resistance poses an existential threat for modern medicine”

This is a rare feel-good moment in the antibiotic space.  Shionogi manufactures and markets cefiderocol, a beta-lactam antibiotic that utilizes a clever siderophore strategy to enter and kill multi-resistant Gram-negative pathogens.

"Chemically induced reprogramming to reverse cellular aging" is the title of a paper that recently appeared in the journal Aging.

Over the past several years, the medical community has learned, to its dismay, that we can experience a “twin-demic” of winter infectious diseases – simultaneous COVID-19 and flu outbreaks resulting in intense stresses on healthcare delivery.